Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From GlySure Ltd.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Start-ups developing technologies to help hospitals avoid preventable medical errors known as “never events” are developing solutions to nosocomial infections, retained surgical objects, pressure ulcers, and medication errors.
Research Briefs: HeartWare Adds Patients To ENDURANCE; GlySure ICU Glucose Trial; Biotronik Home Monitoring
FDA has approved HeartWare’s plan to add more patients to the ENDURANCE trial of its HVAD ventricular assist device as a destination therapy for patients with end-stage heart failure. Results of a pilot trial of GlySure’s continuous glucose monitoring system were presented at a conference in South Africa. More research.
- Monitoring Equipment & Devices
In Vitro Diagnostics
- Glucose Testing
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.